shutterstock.com
Jan 3, 2025, 12:36
Akhil Santhosh: Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, posted on X:
“Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer:
LACC trial MIS associated with higher recurrences and lower DFS compared to open radical hysterectomy, hence the same not endorsed by FDA and NCCN.”
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Authors: Pedro T. Ramirez, Michael Frumovitz, Rene Pareja, Aldo Lopez, Marcelo Vieira, Reitan Ribeiro, Alessandro Buda, Xiaojian Yan, Yao Shuzhong, Naven Chetty, David Isla, Mariano Tamura, Tao Zhu, Kristy P. Robledo, Val Gebski, Rebecca Asher, Vanessa Behan, James L. Nicklin, Robert L. Coleman, Andreas Obermair
Akhil Santhosh
Aldo Lopez
Alessandro Buda
Andreas Obermair
cancer
cervical cancer
David Isla
FDA
hysterectomy
James L. Nicklin
Kristy P. Robledo
LACC trial
Marcelo Vieira
Mariano Tamura
Michael Frumovitz
Naven Chetty
OncoDaily
Oncology
Pedro T. Ramirez
Rebecca Asher
Reitan Ribeiro
Rene Pareja
Robert L. Coleman
Tao Zhu
Val Gebski
Vanessa Behan
Xiaojian Yan
Yao Shuzhong
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 31, 2025, 17:28
Jan 31, 2025, 17:24
Jan 31, 2025, 17:20
Jan 31, 2025, 17:13
Jan 31, 2025, 17:03
Jan 31, 2025, 16:44